More about

Lymphoma

News
January 24, 2023
1 min read
Save

Ukrainian Lymphoma Registry reports seeing half as many patients during war

Ukrainian Lymphoma Registry reports seeing half as many patients during war

NEW ORLEANS — Since war started in Ukraine, tertiary care centers focused on treating cancers saw a 56% decline in patients with lymphoma, a presenter said.

News
January 19, 2023
1 min read
Save

FDA approves Brukinsa for chronic lymphocytic leukemia, small lymphocytic lymphoma

FDA approves Brukinsa for chronic lymphocytic leukemia, small lymphocytic lymphoma

The FDA approved zanubrutinib for treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma.

News
January 19, 2023
1 min read
Save

Global burden of non-Hodgkin lymphoma estimated to increase 1.5-fold by 2040

NEW ORLEANS — Looking at 185 countries, a projection presented at the ASH Annual Meeting and Exhibition suggests the global burden of non-Hodgkin lymphoma will increase by 778,000 cases by 2040.

News
January 17, 2023
2 min read
Save

Anxiety, depression likely with new lymphoma diagnoses

NEW ORLEANS — Patients diagnosed with lymphoma were likely to experience anxiety and depression, lowering overall quality of life, according to a presenter at ASH Annual Meeting and Exhibition.

News
January 15, 2023
5 min watch
Save

Brentuximab vedotin-nivolumab regimen induces response in limited-stage Hodgkin lymphoma

Brentuximab vedotin-nivolumab regimen induces response in limited-stage Hodgkin lymphoma

NEW ORLEANS — Induction with brentuximab vedotin plus AVD chemotherapy followed by nivolumab consolidation exhibited encouraging activity among previously untreated patients with limited-stage non-bulky Hodgkin lymphoma, according to study results.

News
January 12, 2023
2 min watch
Save

Efficacy, safety data support use of lisocabtagene maraleucel at community sites

Efficacy, safety data support use of lisocabtagene maraleucel at community sites

NEW ORLEANS — Lisocabtagene maraleucel can be administered safely in the community setting to patients relapsed or refractory large B-cell lymphoma, according to phase 2 study results.

News
January 05, 2023
5 min watch
Save

Fourth-generation autologous CAR-T product shows efficacy for pretreated lymphoma

Fourth-generation autologous CAR-T product shows efficacy for pretreated lymphoma

NEW ORLEANS — A novel chimeric antigen receptor T-cell therapy showed encouraging early efficacy among heavily pretreated patients with CD19-positive non-Hodgkin lymphoma, according to study results.

News
January 04, 2023
5 min watch
Save

Bendamustine lymphodepletion effective, safe as part of CAR-T for advanced lymphoma

Bendamustine lymphodepletion effective, safe as part of CAR-T for advanced lymphoma

NEW ORLEANS — Bendamustine lymphodepletion resulted in significant CAR T-cell expansion among patients with relapsed or refractory non-Hodgkin lymphoma, according to study results presented at ASH Annual Meeting and Exposition.

News
January 03, 2023
3 min read
Save

Consolidation high-dose chemotherapy plus HSCT extends survival in primary CNS lymphoma

Consolidation high-dose chemotherapy plus HSCT extends survival in primary CNS lymphoma

NEW ORLEANS — Consolidation therapy with high-dose chemotherapy followed by hematopoietic stem cell transplant significantly prolonged PFS among adults with primary central nervous system lymphoma, according to study results.

News
December 29, 2022
4 min watch
Save

Combination active in advanced classic Hodgkin lymphoma

Combination active in advanced classic Hodgkin lymphoma

The addition of brentuximab vedotin and nivolumab to doxorubicin and dacarbazine appeared promising for adults with bulky stage II or stage III/stage IV classic Hodgkin lymphoma, according to study results.

View more